Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03602079
Title Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Klus Pharma Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.